ArticleDrugs & aging2023

Efficacy and Safety of Dupilumab in Older Patients (Aged 80 Years and Above) with Atopic Dermatitis: A Prospective Study.

Xiyuan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.